2IDF.Clincal Guidelines Task Force.Global Guideline for Type 2 Diabet:recommendations for standard,comprehensive,and minimal care[J].Diabet Med,2006,23(6):579-593.
3American Diabetes Association.Standards of medical carein diabetes-2007[J].Diabetes Care,2007,30(Suppl1):4-41.
4Kirstine Brown Frandsen.糖尿病治疗管理的现状[J].国外医学（内分泌学分册）,2005,25(3):172-173. 被引量：28
5Beta-cell deterioration determines the onset and rate of progression of secondary dieary failure in type 2 diabetesmellitus:The 10 ye follow-up of the Belfast Diet Study[J].Diaber Med 1998,15:290- 296.
6Hirsch I B,Bergenstal R M,Parkin C G,et al.A realworld approach to insulin therapy in primary care praetice[J].Clin Diabetes,2005,23:78-86.
8Pratley R E,Weyer C.The role of impairedearly insulin secretion in the pathogenesis of Ⅱ diabetes mellitus[J].Diabetologia,2001,44:929-945.
9Wyer C,Tataranni P A,Bogardus C,et al.Insulin resistance and insulin secretory dysfunctionare independentpredictiorsof worsening of glucose tolerance during each stage of type 2 diabetesdevelopment[J].Diabetes Care,2001,24:89-94.
10Nathan D M,Buse J B,Daidson M B,et al.Management of hyperglycemia in type 2 diabetes:a consensus algorithm for the initation and adjustment of therapy.A consensus statement from the American Diabetesassociationand the European Association for the study of Diaberter[J].Diabetes Care,2006,29(8):1963-1972.
二级参考文献25
1Weyer. Dificiency in AIR predict IGT and Type 2 diabetes. Diabetes Care, 2001,24 : 89-94.
2Haffner SM, Miettinen H, Gaskill SP, et al. Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans. Diabetes, 1995,44: 1386-1391.
3Bruce DG, Chisholm DJ, Leonare H, et al. Physiological importance of deficiency in early prandial insulin secretion in non-in-sulin-dependent diabetes. Diabetes, 1988,37: 736-743.
4Bruttomesso D, Pianta A, Mari A, et al. Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients. Diabetes, 1999,48: 99-105.
5Ilkova H, glaser B, Tunckale A, et al. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment. Diabetes Care, 1997,20:1353-1356.
6Walton C, Godsland IF, Proudler AJ, et al. Effect of body mass index and fat distribution on insulin sensitivity, secretion, and clearance in nonobese healthy men. J Clin Endocrinol Metab,1992,75: 170-175.
7The DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus [J]. N Engl J Med, 1993,329:683-689.
8UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes [J]. Lancet, 1998,352:837-853.
9Pedersen O, Gaede P. Intensified muhifactorial intervention and cardiovascular outcome in type 2 diabetes: the steno-2 study [J]. Metabolism, 2003,52: 19-23.
10Abraira C, Duckworth W, McCarren M, et al. Design of cooperative study of glycemic control and complications in diabetes mellitus type2 [J]. J Diabetes Compl, 2003,17:314-322.
4Visser M,Bouter LM, Mc Quillan GM, et al. Elevated C-reactive protein levels in overweight and obese [J ]. JAMA, 1999, 282 (22) : 2131-2135.
5Csiszar A, Smith KE , Koller A , et al . Regulation of bone mor- phogenetic protein-2 expression in endothelial eels : role of nuclear fac- tor-kappaB activation by tumor necrosis factor-alpha, H2 02, and high in- travascular pressure EJ]. Circulation , 2005 ,111:2364-2372.
